Pharmaceutical News

RSS

Researchers test new drug to treat patients with chylomicronemia syndrome

People with familial chylomicronemia syndrome are born with a genetic mutation that means they can't produce an enzyme called lipoprotein lipase.

9 Aug 2019

New technique protects promising TB vaccine from heat damage

Scientists working on a new tuberculosis vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.

8 Aug 2019

Price of snakebite drug is sky high, but new competitor unlikely to lower costs

Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented its own form of misery.

8 Aug 2019

NSAIDs contribute to cardiovascular side effects in patients with osteoarthritis

Nonsteroidal anti-inflammatory drugs (NSAIDs) can help to control the pain and inflammation in individuals with osteoarthritis, but a new Arthritis & Rheumatology study suggests that NSAIDs contribute to cardiovascular side effects in these patients.

7 Aug 2019

Major step toward creation of vaccine that could neutralize ‘superbug’

Researchers from the Los Angeles Biomedical Research Institute have taken a major step toward the creation of vaccine that could neutralize the culprit behind a growing public health crisis.

6 Aug 2019

Drug used to treat alcohol use disorder reduces craving in heavy drinkers

Researchers at Yale University have identified how naltrexone, a medication used to treat alcohol use disorder, reduces craving and consumption in heavy drinkers.

6 Aug 2019

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

When PDL BioPharma's $40 million blood-pressure medicine faced the threat of a generic rival this year, the company pulled out a little-known strategy that critics say helps keep drugs expensive and competition weak.

5 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

Probiotics for kidney disorders to be showcased at ANNA 2019 in Dallas

Kibow Biotech, Inc., Pennsylvania, will feature its product for Kidney Illness, RENADYL™, at the 50th Anniversary Meeting of the American Nephrology Nurse Association (ANNA) in Dallas, Texas, USA.

From Kibow Biotech Inc. 2 Aug 2019

Company expands development plans for drugs which slow progression to dialysis

Kibow Biotech announces that the focus on supporting and maintaining healthy kidney function with probiotics/prebiotics to potentially delay the progression to dialysis is based on its enteric toxin reduction platform technology termed "Enteric Dialysis®"

From Kibow Biotech Inc. 2 Aug 2019

New drug combination successfully reduces levels of bovine leukemia virus

Scientists have succeeded in reducing levels of the bovine leukemia virus in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor.

2 Aug 2019

Combination of vaccine and medicated cream can reduce recurrence of genital herpes

Yale investigators have shown that the combination of a vaccine and a medicated cream is a promising strategy to dramatically reduce the recurrence of genital herpes.

2 Aug 2019

California bill would fight deals that delay generic drugs

California's attorney general touted a legal victory this week against drugmakers who he said made secretive, backroom deals to keep less expensive drugs off the market.

1 Aug 2019

New leukemia treatment developed from common wild flower

Researchers have discovered how to turn a compound from a common wildflower called Feverfew into a new treatment for leukemia.

1 Aug 2019

Evidence shows ketamine is not opioid and can treat depression easily

Ketamine’s reputation as an antidepressant is restored; it’s not an opioid.

From Johns Hopkins Medicine 1 Aug 2019

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

A new study has shown that SGLT-2 inhibitors used in the treatment of type 2 diabetes do not increase the risk of UTIs over other anti-diabetic medications.

31 Jul 2019

Brand–brand competition unlikely to lower list prices of brand-name drugs

Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women’s Hospital and Harvard Medical School, and colleagues.

From PLOS ONE 31 Jul 2019